In their most recent earnings report Impax Lab indicated that they purchased the license to produce zomig from AstraZeneca UK Limited.
On May 7 I wrote Global Pharm (a division of Impax) a letter inquiring about the generic version of Zoming. They indicated no info available at this time but to visit their website for updates.
I'm guessing that the generic zomig should be released within a year. Keep your fingers crossed!!!